A0300000

(-)-肾上腺素 (+)-酒石酸氢盐

European Pharmacopoeia (EP) Reference Standard

• 别名: 酒石酸肾上腺素, 副肾素 (+)-酒石酸氢盐, L-3,4-Dihydroxy-α-(methylaminomethyl)benzyl alcohol D-hydrogen 酒石酸氢盐, L-Adrenaline D-hydrogentartrate
• 经验公式（希尔记法）: C₉H₁₃NO₃ · C₄H₆O₆
• CAS号: 51-42-3
• 分子量: 333.29
• MDL编号: MFCD00035077
• UNSPSC代码: 41116107
• PubChem化学物质编号: 329770596
• NACRES: NA.24

属性

• 等级: pharmaceutical primary standard
• API类: adrenaline
• 制造商/商品名称: EDQM
• 应用: pharmaceutical (small molecule)
• 包装形式: neat
• SMILES字符串: O[C@H]([C@@H](O)C(O)=O)C(O)=O.CNC[C@H](O)c1ccc(O)c(O)c1
• InChI: 1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;1-,2-/m01/s1
• InChI key: YLXIPWWIOISBDD-NDAAPVSOSA-N
• 基因信息: human ... ADRA1A(148) , ADRA1B(147) , ADRA1D(146) , ADRA2A(150) , ADRA2B(151) , ADRA2C(152) , ADRB1(153) , ADRB2(154) , ADRB3(155)

说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Adrenaline tartrate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生化/生理作用

肾上腺素能受体激动剂。

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

安全信息

• 象形图: GHS06
• 警示用语：: Danger
• 危险声明: H300
• 预防措施声明: P301 + P330 + P331 + P310
• 危险分类: Acute Tox. 1 Oral
• 储存分类代码: 6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
• WGK: WGK 3
• 闪点(°F): Not applicable
• 闪点(°C): Not applicable